Fimbriae-mediated adherence induces mucosal inflammation and bacterial clearance. Consequences for anti-adhesion therapy.
Connell
H
H
Department of Medical Microbiology, Lund University, Sweden.
Agace
W
W
Hedlund
M
M
Klemm
P
P
Shembri
M
M
Svanborg
C
C
D000818:Animals; D001422:Bacterial Adhesion / Q000276:immunology*; D002518:Ceramides / Q000276:immunology; D016207:Cytokines / Q000276:immunology; D004847:Epithelial Cells; D004848:Epithelium / Q000276:immunology; D004926:Escherichia coli / Q000276:immunology / Q000472:pathogenicity; D010861:Fimbriae, Bacterial / Q000276:immunology*; D006801:Humans; D018928:Immunity, Mucosal / Q000276:immunology*; D007249:Inflammation / Q000276:immunology*; D009092:Mucous Membrane / Q000276:immunology; D015398:Signal Transduction / Q000276:immunology; D014552:Urinary Tract Infections / Q000276:immunology; D014774:Virulence
D002518:Ceramides; D016207:Cytokines